Interacting Drugs |
Efavirenz vs Maraviroc |
Security Level |
 |
Mechanism |
Maraviroc: CYP3A4 Inducers (Strong) may decrease the serum concentration of Maraviroc. |
Management |
Increase maraviroc adult dose to 600 mg twice daily when used with strong CYP3A4 inducers. This does not apply to patients also receiving strong CYP3A4 inhibitors. Do not use maraviroc with strong CYP3A4 inducers in patients with Clcr less than 30 mL/min. |
Efavirenz vs Maraviroc
Post Review about Efavirenz vs Maraviroc Click here to cancel reply.
Other Interactions of Efavirenz
Other Interactions of Maraviroc
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.